Drospirenone (3 mg) + Ethinyl Estradiol (0.03 mg) Tablets Relative to Yasmin®

NCT06233058 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: Drospirenone+ Ethinyl Estradiol Tablets-Test product
DRUG: Drospirenone+ Ethinyl Estradiol Tablets-Reference product

Sponsor

Bio-innova Co., Ltd